Structural insights into the triple agonism at GLP-1R, GIPR and GCGR manifested by retatrutide
- Cell Discov. 2024 Jul 17;10(1):77. doi: 10.1038/s41421-024-00700-0.
Affiliations
- 1. State Key Laboratory of Chemical Biology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
- 2. The National Center for Drug Screening, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
- 3. University of Chinese Academy of Sciences, Beijing, China.
- 4. Department of Pharmacology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
- 5. State Key Laboratory of Drug Research, Center for Structure and Function of Drug Targets, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
- 6. University of Chinese Academy of Sciences, Beijing, China. [email protected].
- 7. State Key Laboratory of Drug Research, Center for Structure and Function of Drug Targets, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China. [email protected].
- 8. State Key Laboratory of Chemical Biology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China. [email protected].
- 9. The National Center for Drug Screening, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China. [email protected].
- 10. University of Chinese Academy of Sciences, Beijing, China. [email protected].
- 11. Research Center for Deepsea Bioresources, Sanya, Hainan, China. [email protected].
- 12. Department of Pharmacology, School of Basic Medical Sciences, Fudan University, Shanghai, China. [email protected].
- 13. Research Center for Deepsea Bioresources, Sanya, Hainan, China. [email protected].
- 14. Department of Chemistry, School of Science, The University of Tokyo, Tokyo, Japan. [email protected].
- 15. Engineering Research Center of Tropical Medicine Innovation and Transformation of Ministry of Education, School of Pharmacy, Hainan Medical University, Haikou, Hainan, China. [email protected].
- # Contributed equally.
PMID: 39019866
DOI: 10.1038/s41421-024-00700-0